October 24, 2015 Novartis heart drug gets FDA's 'breakthrough' status Swiss pharmaceuticals company Novartis said on Friday U.S. regulators have given breakthrough therapy status to an investigational treatment for patients with acute heart failure, potentially fast tracking its development and approval.
October 24, 2015 Sanofi wins EU approval for second MS treatment French drugmaker Sanofi said it won approval from European authorities for a second multiple sclerosis treatment, paving the way to start selling both drugs in the region soon.
October 24, 2015 New cancer tools allow patients to reconsider chemo After decades of using one-size-fits-all therapies to combat cancer, doctors are using new tools to help decide when their patients can skip chemotherapy or other harsh treatments.
October 24, 2015 NSAIDS may boost bleeding risk after heart attack For people taking drugs to prevent blood clots after a heart attack, adding pain relievers like ibuprofen may lead to bleeding, stroke or another heart attack, according to a new study.
October 24, 2015 Tapeworm genome points way to better drug treatments Scientists have for the first time mapped the genomes of tapeworms, shedding light on the evolution of one of humankind's oldest parasites and revealing new possibilities for drug treatments
October 24, 2015 Special superglue halts life-threatening bleeding in Kansas baby's brain Doctors at the University of Kansas Hospital have saved an infant with a rare, life-threatening condition by using surgical superglue.
October 24, 2015 After stroke, clot removal saves brain function, studies say Grabbing and removing a clot blocking blood flow to the brain, rather than just administering clot-busting drugs, dramatically improves the likelihood that patients will recover from a stroke, according to two highly-anticipated studies released on Wednesday.
October 24, 2015 Regulators pave way for biosimilar drug breakthrough European regulators have cleared the way for the first serious threat to the makers of multibillion-dollar biotechnology drugs to treat diseases such as cancer and rheumatoid arthritis.
October 24, 2015 Fight over hot new cholesterol drugs may be won in milligrams Two powerful and innovative cholesterol drugs likely to be approved this summer both target the same protein and have been shown to sharply lower LDL in high-risk patients. But there is at least one significant difference between the two offerings: the dosages in which they will be sold.
October 24, 2015 FDA approves Emergent BioSolutions' anthrax treatment Emergent BioSolutions Inc said the U.S. Food and Drug Administration approved its treatment for inhaled anthrax, triggering a $7 million milestone payment from the U.S. Department of Health and Human Services (HHS).
